ADVERTISEMENT

Home|Journals|Articles by Year|Audio Abstracts
 

Original Research

RMJ. 2024; 49(4): 730-733


Assessment of new inflammatory marker for diabetic kidney disease in Type 2 Diabetic patients

Syed Zakir Shah, Aimal Khan, Hamayun Mumtaz, Iffat Naiyar, Muddasar Pervaiz, Waleed Bin Abdullah.



Abstract
Download PDF Post

Objective: To evaluate the neutrophil-lymphocyte ratio (NLR) as a predictor of inflammatory markers for diabetic nephropathy (DN) in type 2 diabetic patients.
Methodology: This descriptive observational study was conducted at medicine department of Pakistan Institute of Medical Sciences, Islamabad from 1st March 2021 to 1st Jan 2022). The non-probability convenience method of sampling was used for selecting patients aged 18 to 70 years belonging to both genders. HbA1C levels and microalbuminuria along with a CBC and RFTs were performed from the hospital laboratory. Microalbuminuria and N/L ratio were determined.
Results: Out of 200 subjects, 92 were found to be diagnosed with DN and 108 had normal renal function. T-test indicated the statistical relevance of NLR to DN subjects, however, there was no intergroup difference in individual TLC count. On the other hand, inter-group statistical relevance was observed in absolute neutrophil count (ANC) and absolute lymphocyte count (ALC).
Conclusion: For its early detection of DN, NLR a predictor of inflammatory markers can serve as an important biomarker.

Key words: Glomerular filtration rate, diabetic kidney disease, neutrophil-to-Lymphocyte ratio, total lymphocyte count.





Bibliomed Article Statistics

12
20
25
18
29
24
18
14
11
27
15
9
R
E
A
D
S

40

40

16

8

16

9

18

11

7

9

9

7
D
O
W
N
L
O
A
D
S
010203040506070809101112
2025

Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Author Tools
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.